Orthofix Medical Inc. Common Stock (DE) financials
$9.75−0.91%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $210.9M | $196.7M | $219.9M | $205.6M | $203.1M | $193.6M | $215.7M | $196.6M | $198.6M | $188.6M | $200.4M | $184.0M |
| Gross profit | $149.7M | $139.5M | $156.3M | $148.5M | $139.5M | $121.6M | $148.8M | $135.1M | $134.7M | $127.2M | $136.6M | $119.8M |
| Gross margin | 71.0% | 70.9% | 71.1% | 72.2% | 68.7% | 62.8% | 69.0% | 68.7% | 67.8% | 67.5% | 68.2% | 65.1% |
| Operating income | -$8.1M | -$14.4M | $494.0K | -$17.0M | -$16.0M | -$48.9M | -$11.5M | -$18.9M | -$24.9M | -$29.3M | -$18.3M | -$24.4M |
| Net income | -$15.8M | -$20.9M | -$2.2M | -$22.8M | -$14.1M | -$53.1M | -$29.1M | -$27.4M | -$33.4M | -$36.0M | -$22.2M | -$28.9M |
| Net margin | −7.5% | −10.6% | −1.0% | −11.1% | −6.9% | −27.4% | −13.5% | −13.9% | −16.8% | −19.1% | −11.1% | −15.7% |
| Diluted EPS | $-0.39 | $-0.52 | $-0.06 | $-0.57 | $-0.36 | $-1.35 | $-0.76 | $-0.71 | $-0.88 | $-0.95 | $-0.60 | $-0.77 |
| EBITDA | $9.0M | $2.8M | $17.3M | -$1.4M | $4.0M | $3.3M | $9.5M | $2.8M | -$6.5M | -$6.0M | -$14.6M | -$7.8M |
| Operating cash flow | -$6.2M | -$17.6M | $27.7M | $12.4M | $11.6M | -$18.4M | $23.7M | $11.7M | $9.0M | -$18.6M | -$8.8M | $1.3M |
| Free cash flow | -$18.9M | -$28.3M | $16.8M | $2.5M | $4.5M | -$25.1M | $15.2M | $5.9M | -$732.0K | -$29.4M | -$25.1M | -$20.6M |
| Diluted shares | 40.9M | 40.5M | 40.0M | 39.8M | 39.5M | 39.2M | 38.3M | 38.5M | 38.0M | 37.7M | 37.2M | 37.2M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $103.8M | $120.3M | $82.0M | $62.9M | $65.6M | $58.0M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $234.6M | $234.4M | $175.3M | $175.3M | $175.3M | $175.3M |
| Total assets | $873.0M | $886.6M | $850.6M | $832.6M | $837.2M | $823.1M |
| Total liabilities | $443.8M | $451.4M | $400.6M | $390.1M | $378.8M | $364.9M |
| Shareholders' equity | $429.2M | $435.2M | $450.0M | $442.5M | $458.3M | $458.3M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology